Post by
BarstoolSage on Oct 28, 2022 9:33pm
Updated facts
The financing was necessary to survive and has been announced but not yet closed.
The financing is dilutive with significant added share count and low priced warrants
There have been no announced NXO revenue contracts beyond the Pristine Surgical deal which if Pristine begins to earn revenues 4Q/2022 means NXO gets cash in say mid 23 if any is owed
The Selten deal does not appear to have closed
ALL ELSE IS NOISE
Comment by
Damn1212 on Oct 29, 2022 9:48am
@ Bartool The pristine deal is no longer mentioned anywhere in the last MD&A documents released by the company. I think the deal with pristine is no longer existing. If it was , it would be in the MD&A docs as it has been for the last quarters. Your opinion on the subject ?
Comment by
BarstoolSage on Oct 29, 2022 11:12am
Would loss of a contract not be a reportable event?
Comment by
Damn1212 on Oct 29, 2022 11:20am
@barstool At this point we are both in the dark. 1 thing is for sure Qualcomm Arm Nvidia NTEK All are mentioned in MD&A Pristine isnt ... it was always mentioned before. It isnt anymore. We could ask IR but they havnt answered us in 8 months
Comment by
ratsnake220 on Oct 29, 2022 6:43pm
Barstool...you know the nxo model...promise sales on the record and then never walk back the failure to deliver.....They simply have nothing?